Inflammatory response in patients with malignant obstructive jaundice

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 1, 2007, Pages 94-102

  Ljungdahl, Mikael ^a   Österberg, Johanna ^a   Ransjö, Ulrika ^a   Engstrand, Lars ^a,b   Haglund, Ulf ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Apoptosis; Bacterial translocation; Cytokines; Endotoxins; Lymphocytes; Obstructive jaundice; Surgery

Indexed keywords

CASPASE 3; CHLORDANE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 6; T LYMPHOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISEASE; ADULT; AGED; APOPTOSIS; ARTICLE; BACTERIUM; BACTERIUM CULTURE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE DEPLETION; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MICROBIOLOGY; OBSTRUCTIVE JAUNDICE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BACTERIA; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIGESTIVE SYSTEM NEOPLASMS; ENDOTOXINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAUNDICE, OBSTRUCTIVE; LYMPH NODES; MACROPHAGES; MALE; MESENTERY; MIDDLE AGED; T-LYMPHOCYTES;

EID: 33845956796     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600825190     Document Type: Article

References (36)

1. Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM, et al. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 1992;112:891-6.
2. Kimmings AN, van Deventer SJH, Obertop H, Rauws EAJ, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg 1995;181:567-81.
3. Nomura T, Shirai Y, Hatakeyama K. Impact of bactibilia on the development of postoperative abdominal septic complications in patients with malignant biliary obstruction. Int Surg 1999;84:204-8.
4. Welsh FK, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, et al. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 1998;227:265-72.
5. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979;23:403-11.
6. Deitch EA, Sittig K, Berg R, Specian RDL. Obstructive jaundice promotes bacterial translocation. Am J Surg 1990;159:79-84.
7. Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000;92:276-82.
8. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002;131:241-4.
9. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992;15:1132-6.
10. Akiyama T, Hasegawa T, Sejima T, Sahara H, Seto K, Saito H, et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology 1998;45:665-71.
11. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994;57:316-36.
12. Ding JW, Andersson R, Stenram U, Lunderquist A, Bengmark S. Effect of biliary decompression on reticuloendothelial function in jaundiced rats. Br J Surg 1992;79:648-52.
13. Österberg J, Johnsson C, Gannedahl G, Westlund A-M, Haglund U. Alterations in mucosal immune cell distribution in septic rats. Shock 1997;7:182-5.
14. Österberg J, Ljungdahl M, Lundholm M, Engstrand L, Haglund U. Microbial translocation and inflammatory response in patients with acute peritonitis. Scand J Gastroenterol 2004;39:657-64.
15. Murray PR, Balows A. Manual of clinical microbiology. American Society of Microbiology; 1999.
16. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, et al, editors. Leukocyte typing V: white cell differentiation antigens. London, UK: Oxford University Press; 1995.
17. Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, et al. KPI (CD68): a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42:414-21.
18. Povoski SP, Karpeh MS, Conlon KC, Blumgart LH, Brennan MF. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999;230:131-42.
19. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993;218:111-9.
20. Luiten EJT, Hop WCJ, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of acute pancreatitis. Ann Surg 1995;222:1-6.
21. Sagar PM, MacFie J, Sedman P, May J, Mancey-Jones B, Johnstone D. Intestinal obstruction promotes gut translocation of bacteria. Dis Colon Rectum 1995;38:640-4.
22. Sileri P, Morini S, Sica GS, Schena S, Rastellini C, Gaspari AL, et al. Bacterial translocation and intestinal morphological findings in jaundiced rats. Dig Dis Sci 2002;47:929-34.
23. Kuzu MA, Kale IT, Col C, Tekeli A, Tanik A, Koksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology 1999;46:2159-64.
24. Schoeffel U, Pelz K, Häring RU, Amberg R, Schandl R, Urbaschek R, von Spect BU, Farthmann EH. Inflammatory consequences of the translocation of bacteria and endotoxin to mesenteric lymph nodes. Am J Surg 2000;180:65-72.
25. Su CH, Peng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 1992;16:536-40.
26. Ballinger AB, Woolley JA, Ahmed M, Mulcahy H, Alstead EM, Landon J, et al. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 1998;42:555-9.
27. Kimmings N, Sewnath ME, Mairuhu WM, Van Zanten AP, Rauws EA, Van Deventer SJ, et al. The abnormal lipid spectrum in malignant obstructive jaundice in relation to endotoxin sensitivity and the result of preoperative biliary drainage. Surgery 2001;129:282-91.
28. Kimmings AN, van Deventer SJH, Obertop H, Rauws EAJ, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000;46:725-31.
29. Kennedy JA, Lewis H, Clements WD, Kirk SJ, Campbell G, Halliday MI, et al. Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg 1999;86:1410-4.
30. Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, et al. Anti-inflammatory response in patients with obstructive jaundice caused by biliary malignancy. J Gastroenterol Hepatol 2001;16:467-72.
31. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001;166:6952-63.
32. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992;11:95-103.
33. Sun EW, Shi YF. Apoptosis, the quiet death silences the immune system. Pharmacol Ther 2001;92:135-45.
34. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999;96:14541-6.
35. Seubert JM, Darmon AJ, El-Kadi AO, D'Souza SJ, Bend JR. Apoptosis in murine hepatoma hepa 1c1c7 wild-type, C12, and C4 cells mediated by bilirubin. Mol Pharmacol 2002;62:257-64.
36. Sheen-Chen SM, Hung KS, Ho HT, Chen WJ, Eng HL. Effect of glutamine and bile acid on hepatocyte apoptosis after bile duct ligation in the rat. World J Surg 2004;28:457-60.